share_log

HC Wainwright & Co. Maintains Buy on Sangamo Therapeutics, Maintains $3 Price Target

Moomoo 24/7 ·  Mar 13 12:48

HC Wainwright & Co. analyst Patrick Trucchio maintains Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $3 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment